Notably, research on AD and other neurodegenerative conditions has revealed that the perturbation of lipid raft domains can impair RELN/ApoER2 signaling, resulting in deficits in memory, learning, and neuroplasticity (Christina M et al., 2024). Here, RELN is linked to Alzheimer disease.